⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6559802 | 0.35 | — | — | |
| SCHEMBL29889134 | 0.35 | — | — | |
| Water SCHEMBL25437472 | 0.35 | — | — | |
| SCHEMBL5134016 | 0.35 | — | — | |
| SCHEMBL29612863 | 0.35 | — | — | |
| Hydrochloric Acid SCHEMBL72335 | 0.25 | — | — | |
| Fluoride Ion SCHEMBL73611 | 0.25 | — | — | |
| SCHEMBL74539 | 0.25 | — | — | |
| SCHEMBL1629906 | 0.25 | — | — | |
| SCHEMBL1179177 | 0.25 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163495-A1 | TRICYCLIC COMPOUNDS AS CYP1 INHIBITORS | THE GENERAL HOSPITAL CORPORATION | 2021-06-03 | — | — | US | claimed |
| EP-3641756-A1 | TRICYCLIC COMPOUNDS AS CYP1 INHIBITORS | The General Hospital Corporation (US) | 2020-04-29 | — | — | EP | claimed |
| US-10206398-B2 | Five-membered C-N-attached aryl sulphide and aryl sulphoxide derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-02-19 | — | — | US | claimed |
| WO-2018232251-A1 | TRICYCLIC COMPOUNDS AS CYP1 INHIBITORS | THE GENERAL HOSPITAL CORPORATION (US) | 2018-12-20 | — | — | WO | claimed |
| EP-3230267-B1 | FIVE-MEMBERED C-N LINKED ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2018-09-26 | — | — | EP | claimed |
| US-20170367333-A1 | FIVE-MEMBERED C-N-ATTACHED ARYL SULPHIDE AND ARYL SULPHOXIDE DERIVATIVES AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-12-28 | — | — | US | claimed |
| EP-3230267-A1 | FIVE-MEMBERED C-N BONDED ARYL SULPHIDE AND ARYL SULPHOXIDE DERIVATIVES AS PEST CONTROL AGENTS | Bayer CropScience Aktiengesellschaft (DE) | 2017-10-18 | — | — | EP | claimed |
| WO-2016091857-A1 | FIVE-MEMBERED C-N BONDED ARYL SULPHIDE AND ARYL SULPHOXIDE DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-06-16 | — | — | WO | claimed |
| EP-1658081-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA Bioscience nv (BE) | 2006-05-24 | — | — | EP | claimed |
| WO-2005021003-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2005-03-10 | — | — | WO | claimed |
| US-20040186156-A1 | Substituted N-(1,4,5,6,-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-09-23 | — | — | US | claimed |
| US-6747046-B2 | ANTITUMOR, ANTI CELL PROLIFERATION | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-06-08 | — | — | US | claimed |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2004-04-22 | — | — | US | claimed |
| US-20030236255-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2003-12-25 | — | — | US | claimed |
| US-20030212121-A1 | Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-11-13 | — | — | US | claimed |
| WO-2003029223-A1 | SUBSTITUTED N-(1,4,5,6-TETRAHYDROCYCLOPENTAPYRAZOL-3-YL) DERIVATIVES AND THE USE OF THE SAME FOR THE TREATMENT OF CANCER | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | WO | claimed |
| US-20240231224-A9 | HALOGEN-AND ALIPHATIC-CONTAINING ORGANOTIN PHOTORESISTS AND METHODS THEREOF | LAM RESEARCH CORPORATION | 2024-07-11 | — | — | US | disclosed |
| US-12030858-B2 | PARP inhibitors for treating cancer and asthma | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-07-09 | — | — | US | disclosed |
| US-20030212121-A1 | Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-11-13 | — | — | US | disclosed |
| WO-2003029223-A1 | SUBSTITUTED N-(1,4,5,6-TETRAHYDROCYCLOPENTAPYRAZOL-3-YL) DERIVATIVES AND THE USE OF THE SAME FOR THE TREATMENT OF CANCER | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | WO | disclosed |